VISUAL ACUITY LOSS AFTER PANRETINAL PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC RETINOPATHY: A SYSTEMATIC REVIEW
Aim: Proliferative diabetic retinopathy (PDR) is a more serious clinical presentation of diabetic retinopathy. Panretinal photocoagulation (PRP) is an effective laser treatment for PDR. The heat from the laser shrinks the blood vessels to prevent them from re-growing. However, in most cases, severe visual loss still develops despite therapy. The aim of this study was to examine the effect on visual acuity after PRP in PDR by conducting a systematic review.
Methods: The search was systematically done on seven databases; MEDLINE, SCIENCE DIRECT, CINAHL COMPLETE, COCHRANE, SCOPUS, WEB OF SCIENCE and EMBASE. The search focused on any studies related to the effect of PRP on visual acuity in PDR. The search strategies were done by using keywords related to “Proliferative Diabetic Retinopathy”, “Panretinal Photocoagulation” and “Visual Acuity”.
Results: A total of 1775 abstracts were initially identified. 575 abstracts were removed after duplication. The remaining of 1200 abstracts were reviewed by looking at the titles, abstracts and full papers using pre-determined inclusion and exclusion criteria, after which only two were included in the review. These two studies showed that there is loss on visual acuity immediately after PRP treatment on PDR, but time to the recovery of vision varies from nine days to three months.
Conclusion: There were only two studies on the effect of PRP on visual acuity in PDR. Therefore, more research which specifically focused on the effect of PRP should be carried out to investigate more on the effectiveness of the treatment.
Addoor, K. R., S. V. Bhandary, R. Khanna, L. G. Rao, K. D. Lingam, V. Binu, S. Shivaji and M. Nandannaver (2011). "Assessment of awareness of diabetic retinopathy among the diabetics attending the peripheral diabetic clinics in Melaka, Malaysia." Med J Malaysia 66(1): 49.
Aiello, L. P. (2014). "Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study." Diabetes Care 37(1): 17-23.
Barber, A. J. (2003). "A new view of diabetic retinopathy: a neurodegenerative disease of the eye." Progress in Neuro-Psychopharmacology and Biological Psychiatry 27(2): 283-290.
Bressler, N. M., R. W. Beck and I. F. L. Ferris (2011). "Panretinal photocoagulation for proliferative diabetic retinopathy." New England Journal of Medicine 365(16): 1520-1526.
Bressler, N. M., R. W. Beck and F. L. Ferris Iii (2011). "Panretinal photocoagulation for proliferative diabetic retinopathy." New England Journal of Medicine 365(16): 1520-1526.
Danis, R. P. and M. D. Davis (2008). Proliferative diabetic retinopathy. Diabetic Retinopathy, Springer: 29-65.
Dogru, M., M. Nakamura, M. Inoue and M. Yamamoto (1999). "Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation." Japanese Journal of Ophthalmology 43(3): 217-224.
Fong, D. S., A. Girach and A. Boney (2007). "Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: A literature review." Retina 27(7): 816-824.
Giuliari, G. P. (2012). "Diabetic retinopathy: Current and new treatment options." Current Diabetes Reviews 8(1): 32-41.
Googe, J., A. J. Brucker, N. M. Bressler, H. Qin, L. P. Aiello, A. Antoszyk, R. W. Beck, S. B. Bressler, F. L. Ferris, A. R. Glassman, D. Marcus and C. R. Stockdale (2011). "Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation." Retina 31(6): 1009-1027.
Group, E. D. P. R. (2004). "The prevalence of diabetic retinopathy among adults in the United States." Archives of ophthalmology 122(4): 552.
Grunwald, J. E., A. J. Brucker, B. L. Petrig and C. E. Riva (1989). "Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy." Ophthalmology 96(10): 1518-1522.
Letchuman, G., W. Wan Nazaimoon, W. Wan Mohamad, L. Chandran, G. Tee, H. Jamaiyah, M. Isa, H. Zanariah, I. Fatanah and Y. Ahmad Faudzi (2010). "Prevalence of diabetes in the malaysian national health morbidity survey III 2006." Med J Malaysia 65(3): 180-186.
McDonald, H. R. and H. Schatz (1985). "Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy." Ophthalmology 92(3): 388-393.
Muraly, P., P. Limbad, K. Srinivasan and K. Ramasamy (2011). "Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparitive study." Retina 31(7): 1359-1365.
Simó, R. and C. HERNandez (2009). "Advances in the medical treatment of diabetic retinopathy." Diabetes Care 32(8): 1556-1562.
Soman, M., S. Ganekal, U. Nair and K. Nair (2012). "Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema." Clinical ophthalmology (Auckland, NZ) 6: 2013.
Waisbourd, M., M. Goldstein and A. Loewenstein (2011). "Treatment of diabetic retinopathy with anti‐VEGF drugs." Acta ophthalmologica 89(3): 203-207.
Wild, S., G. Roglic, A. Green, R. Sicree and H. King (2004). "Global prevalence of diabetes estimates for the year 2000 and projections for 2030." Diabetes care 27(5): 1047-1053.
Wong, R., J. Khan, T. Adewoyin, S. Sivaprasad, G. B. Arden and V. Chong (2008). "The ChromaTest, a digital color contrast sensitivity analyzer, for diabetic maculopathy: A pilot study." BMC Ophthalmology 8.
Yau, J. W., S. L. Rogers, R. Kawasaki, E. L. Lamoureux, J. W. Kowalski, T. Bek, S.-J. Chen, J. M. Dekker, A. Fletcher and J. Grauslund (2012). "Global prevalence and major risk factors of diabetic retinopathy." Diabetes care: DC_111909.
Yoon, Y. H., J. Lee and Y. J. Kim (1996). "Preservation of retinal sensitivity in central visual field after panretinal photocoagulation in diabetics." Korean Journal of Ophthalmology 10: 48-54.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.